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Abstract
Epigenetic mechanisms of gene regulation in context of cardiovascular diseases are of con-
siderable interest. So far, our current knowledge of the DNA methylation profiles for athero-
sclerosis affected and healthy human vascular tissues is still limited. Using the Illumina
Infinium Human Methylation27 BeadChip, we performed a genome-wide analysis of DNA
methylation in right coronary artery in the area of advanced atherosclerotic plaques,
atherosclerotic-resistant internal mammary arteries, and great saphenous veins obtained
from same patients with coronary heart disease. The resulting DNAmethylation patterns
were markedly different between all the vascular tissues. The genes hypomethylated in
athero-prone arteries to compare with atherosclerotic-resistant arteries were predominately
involved in regulation of inflammation and immune processes, as well as development. The
great saphenous veins exhibited an increase of the DNA methylation age in comparison to
the internal mammary arteries. Gene ontology analysis for genes harboring hypermethy-
lated CpG-sites in veins revealed the enrichment for biological processes associated with
the development. Four CpG-sites located within theMIR10B gene sequence and about 1 kb
upstream of the HOXD4 gene were also confirmed as hypomethylated in the independent
dataset of the right coronary arteries in the area of advanced atherosclerotic plaques in
comparison with the other vascular tissues. The DNA methylation differences observed in
vascular tissues of patients with coronary heart disease can provide new insights into the
mechanisms underlying the development of pathology and explanation for the difference in
graft patency after coronary artery bypass grafting surgery.
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Introduction
Atherosclerosis underlies the development of a majority of cardiovascular diseases, which are
among the leading causes of mortality worldwide. Different vascular beds vary in their susceptibility
to the development of atherosclerosis. Coronary artery has the highest prevalence of atherosclerotic
plaques in comparison with other arteries. It has been established that internal mammary arteries
as well as great saphenous veins are resistant to the development of atherosclerosis [1]. However,
the outcome of venous bypass grafts is poor because veins are more prone to occlusive disease than
artery grafts. Understanding of the mechanisms of vascular differences in disease development may
yield insight into factors that affect atherosusceptibility as well as disease progression.
Although atherosclerosis is caused by the interaction of multiple genetic and environmental
factors, these explain only a portion of the total disease risk. Epigenetic mechanisms that
underly this pathology have become a promising area of research [2, 3]. Compared to genetic
factors, epigenetic variation is much more suitable to explain the progressive and age-related
nature of atherosclerosis characterized by sex and tissue specificity. Aberrant epigenetic pat-
terns can be acquired during developmental stages under environmental influence.
The most widely studied and best-characterized epigenetic marker in human genome is
DNAmethylation. DNAmethylation in tissues usually occurs within the context of CpG-
dinucleotide sequences (CpG-sites). In somatic mammalian cells, the majority of CpG-sites are
methylated. However, CpG-sites located in regions of increased CG-density, known as CpG-
islands, generally have low levels of methylation. DNAmethylation at gene promoters is impor-
tant for transcriptional regulation, with dense promoter hypermethylation around the transcrip-
tion start sites being associated with repressed expression of genes. Outside of CpG-islands,
intragenic DNAmethylation has been linked to transcriptional and splicing activities [4].
In vascular tissues of patients with atherosclerosis, DNAmethylation alterations of
15-lipoxygenase (ALOX15), estrogen receptors (ESR1 and ESR2), monocarboxylate transporter
3 (MCT3), and tissue factor pathway inhibitor 2 (TFPI2) genes have been reported using a can-
didate gene approach [5–9]. Using high throughput microarray technology, genome-wide DNA
methylation patterns can be evaluated simultaneously, and novel tissue-specific molecular tar-
gets can be identified. However, our knowledge about the impact of genome-wide alterations of
DNAmethylation on the atherosclerosis phenotype in humans is still limited [10–12].
DNA methylation pattern in many tissues is highly correlated with the chronological age.
Recently, Horvath [13] developed a multi-tissue predictor of DNA methylation age. He pro-
posed that DNA methylation age measures the cumulative work done by the epigenetic main-
tenance system and epigenetic clock can be used to identify tissues affected by disease [13].
In the current study we performed a comparative analysis of DNAmethylation patterns in
right coronary arteries in the area of advanced atherosclerotic plaques (CAP), internal mam-
mary arteries (IMA), and great saphenous veins (GSV) derived from the same individuals with
coronary artery atherosclerosis, using Illumina HumanMethylation27 BeadChip microarrays.
We hypothesize that DNAmethylation differences are the key to distinguish CAP from the
IMA with respect to their liability to the development of atherosclerosis. A comparison of
DNAmethylation patterns between GSV and IMA can provide an explanation for the differ-
ence in graft patency after coronary artery bypass grafting surgery.
Materials and Methods
Sample collection and processing
A total of 21 Russian men (age 57.76 ± 6.9 years, mean ± S.E.) who underwent surgery for se-
vere coronary artery stenosis were recruited (Table 1). Sixteen patients (76.2%) had a history of
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heart failure prior to surgery. Hypertension was diagnosed in all patients. Fourteen men
(66.7%) had hyperlipidaemia. Diabetes mellitus was found in 4 patients (19.0%). The study
protocol was approved by the Ethical Committee of the Research Institute for Medical Genetics
and written informed consents were obtained from all the participants.
Matched biopsy specimens were obtained from the right coronary artery in the area of ad-
vanced atherosclerotic plaques (CAP), internal mammary arteries (IMA) and great saphenous
veins (GSV) of the patients undergoing coronary artery bypass graft surgery. The atheroscle-
rotic lesions of right coronary artery were classified as advanced according to surgeon recom-
mendations. Immediately after the operation, samples were examined by a pathologist, cleaned
from calcifications, fatty deposits and thrombotic material, and washed with sterile physiologi-
cal saline solution. All samples were snap-frozen in liquid nitrogen and stored at -80°C until
further use.
In our study several vascular tissue samples were stained with hematoxylin and eosin or
immunostained with antibodies against smooth muscle-specific α-actin and CD68. Smooth
muscle cells were predominated in all analyzed vascular tissues. CAP, IMA and GSV showed a
variable degree of infiltration with macrophages. Specimens taken from the CAP contained a
large accumulation of macrophages to compare with IMA and GSV. For DNA methylation mi-
croarray profiling, we selected match-paired specimens (CAP, IMA, GSV) from six patients.
For confirmation by pyrosequencing and replication, match-paired tissue samples from all 21
individuals were used.
DNAmethylation profiling
The frozen tissue samples were homogenized using the Minilys homogenizer (Bertin Technolo-
gies) followed by isolation of DNA by standard proteinase K digestion and phenol/chloroform
extraction method. Eighteen samples of genomic DNA were bisulfite converted using EZ DNA
Methylation Kit (Zymo Research). DNAmethylation level was measured using the Illumina
Infinium HumanMethylation27 BeadChip according to standard protocol [14]. Microarray’s
probes interrogate the methylation state of 27578 individual CpG-sites located predominately in
CpG-islands within proximal promoter regions, between 1.5 kb upstream and 1 kb downstream
of the transcription start sites of 14475 consensus coding sequence genes throughout the
Table 1. Baseline characteristics of the study subjects.
Clinical parameters All patients, n = 21
Age (years) 57.76±6.9
BMI (kg m−2) 29.68±3.9
Heart attack 16 (76.2)
Hypertension 21 (100)
Smoking 12 (57.1)
Diabetes mellitus 4 (19.0)
Glucose (mmol/L) 6.29±1.4
Cholesterol (mmol/L) 5.62±1.1
Triglycerides (mmol/L) 2.14 (0.81–9.03)
Apolipoprotein B/apolipoprotein A1 ratio 4.2 (2.53–7.70)
Hypertension was deﬁned as a systolic blood pressure 140 or diastolic 90mm Hg or the current use of
antihypertensive drugs. Patients were categorized as smokers if they were current smokers or had stopped
smoking for less than 1 year. Obesity was appreciated by the Body Mass Index (BMI). Quantitative values
are presented as mean±S.E. or median (min-max) and qualitative values as n (percentage).
doi:10.1371/journal.pone.0122601.t001
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genome. Furthermore 110 miRNA promoters are targeted with 254 CpG loci probes [14].
Bisulfite-converted genomic DNA was denatured, whole-genome amplified, fragmented and
subsequently hybridized to a microarray. Fluorescently stained chip was scanned by the Illu-
mina BeadArray Reader. Quality control was conducted in GenomeStudio software using the
methylation module according to the manufacturer’s recommendations (Illumina). The data of
DNAmethylation in our study have been deposited in the Gene Expression Omnibus (GEO)
database and are available through GSE62867 accession number (http://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi?acc=GSE62867).
DNA pyrosequencing analysis
DNAmethylation status of CpG-sites ofHOXD4 gene was assessed by pyrosequencing using
PyroMark Q24 (Qiagen) according to the manufacturer’s instructions. Primers for pyrose-
quencing were designed to encompass the CpG-sites assayed on the Illumina Infinium array.
The region studied for the differential DNAmethylation encompasses four CpG-dinucleo-
tides located within theMIR10B gene sequence and about 1 kb upstream of theHOXD4 gene
(chr 2q31.1; CpG-site 1 (cg01152019): 177,015,044, CpG-site 2 (cg14399060): 177,015,070,
CpG-site 3: 177,015,088, and CpG-site 4: 177,015,104; UCSC Genome Browser Ch37/hg19).
For the bisulfite PCR, 40–50 ng of bisulfite-converted DNA was amplified using 2 U Hot
Start Taq DNA polymerase (SibEnzyme) and 0.2 μM forward (5’-GGTTATTTGAATTGTTT
TAGAAAG-3’) and reverse (5’-[Biotin]- CACTTTAATCTCTAACTATTCC-3’) primers in
50 μl reaction volume including 0.2 mM dNTPs and 2 mMMgCl2. The PCR conditions were:
95°C for 5 min followed by 42 cycles of 95°C for 30 s, 56°C for 45 s, 72°C for 30 s, and final
elongation step at 72°C for 5 min. Biotin-labeled single-stranded amplicons were retrieved and
subjected to pyrosequencing with use of 0.3 μM sequencing primer 5’-TTTTGGGTGGGATT
TAGAGGTTGT-3’ according to the manufacturer’s protocol. The percent of methylation for
each of the CpGs within the target sequence was calculated using PyroQ CpG Software (Qia-
gen). Non-CpG cytosine residues were used as built-in controls to verify bisulfite conversion.
Each marker was tested in two replicates and their average was used in the statistical analysis.
Statistical analysis
The results presented in our study were obtained using the log2 ratio between unmethylated
and methylated probes (M-value) and the beta-statistics [methylated/(unmethylated + methyl-
ated)]. Illumina’s GenomeStudio software was used to analyze BeadArray data to assign site-
specific DNA methylation beta-values to each CpG-site. The beta-value represents a quantita-
tive measure of the DNAmethylation level of specific CpG-sites and ranges from 0 (completely
unmethylated) to 1 (completely methylated).
The raw data were imported into R environment for statistical computing v3.0.1 (http://
www.R-project.org) and analyzed using Bioconductor lumi package [15]. The data were further
inspected for quality metrics, adjusted for color channel imbalance and quantile-normalized.
All probes with detection p-values0.01 were removed.
DNA methylation age of tissues was calculated using R-code developed by Horvath (2013).
Multi-dimensional scaling was used to display the distance between individual samples based
on their methylation status. All CpG-sites were used for scaling.
Differentially methylated CpG-sites (expressed as M-values) between groups were identified
using limma package [16]. Benjamini-Hochberg false-discovery rate (FDR) method was ap-
plied to control for multiple tests. FDR-adjusted p<0.05 and delta beta0.2 or delta beta
-0.2 were used as cut-off values as indicated in the volcano plot. Heatmap of all samples was
drawn with samples in rows and CpG-sites in column. For clearer presentation of differentially
DNAMethylation Patterns in Human Coronary Atherosclerosis
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methylated CpG-sites and genes, we chose a cutoff value of 0.4 for the heatmaps instead of the
0.2 set for the analysis.
Functional enrichment analysis of genes containing differentially methylated CpG-sites was
performed using the web-based GEne SeT AnaLysis Toolkit [17]. The reference gene set com-
prised the genes represented on the Illumina arrays. Gene Ontology (GO) categories were found
by a hypergeometric statistical test. p-values were corrected for multiple testing using FDR.
Statistically significant differences in DNAmethylation level between groups were identified
by ANOVA with post-hoc test. An enrichment of hyper- and hypomethylated CpG-sites versus
all CpG-sites was calculated using Fisher’s exact test. Correlations between variables were esti-
mated using Pearson’s correlation coefficient. The significance level of p<0.05 was applied.
These analyses were carried out using GraphPad software (InStat).
Results
The pipeline of the experiment is given in Fig 1.
DNAmethylation profile of vascular tissues
The analysis of DNAmethylation profiles in four matched sets of tissues from 6 individuals
was performed using Infinium HumanMethylation27 BeadChip assay (Illumina), which con-
tains 27578 CpG targets covering 14495 genes. After quality control, methylation of 27378
CpG-sites (14391 genes) was analyzed.
Fig 1. Flow chart describing experiment and analysis.
doi:10.1371/journal.pone.0122601.g001
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DNAmethylation age per tissue was moderately correlated with corresponding chronolog-
ical age (r = 0.67, 95%CI 0.36–0.84, p = 0.0004). However, GSV showed evidence of signifi-
cantly higher mean DNA methylation age than IMA (65.3±7.3 vs. 52.7±5.2, respectively;
p<0.05; Fig 2).
Multi-dimensional scaling plot revealed that the DNA methylation patterns differed more
between tissue types than between individuals (Fig 3). In terms of DNA methylation, IMA and
GSV were closer to each other than to CAP. The IMA and GSV tissues showed minimal differ-
ences between individual methylation profiles, whereas the CAP was characterized by high
interindividual variability of methylation profiles.
The average beta-values for all CpG-sites as well as inside of CpG-islands were higher in
the CAP tissues than in the IMA and GSV (Table 2). The hypomethylated CpG-sites (beta-
value0.2) were registered less frequently in CAP (0.65) as compared to IMA (0.67; p<0.05).
Differentially methylated CpG-sites for CAP and IMA tissues
Differential methylation analysis between CAP and IMA tissues revealed 358 CpG-sites exhib-
ited a methylation level difference as little as 0.2 (S1 Table). Among these differentially methyl-
ated CpG-sites, 164 (45.8%) were hypomethylated in CAP as compared to IMA as indicated in
the volcano plot (Fig 4). GO analysis revealed that these CpG-sites mainly located within the
genes involved in regulation of inflammation and immune processes, as well as development
(S2 Table). By contrast, no statistically significant GOs were found for the genes harboring 194
(54.2%) hypermethylated sites.
Within the list of 358 CpG-sites, there were 22 loci covering 18 genes with the greater
magnitude of differential methylation (delta beta0.40 or-0.40) (Figs 4 and 5). The
Fig 2. Themean chronological age and DNAmethylation age (DNAm) of vascular tissues: right coronary artery in the area of advanced
atherosclerotic plaques (CAP), internal mammary arteries (IMA), and great saphenous veins (GSV).
doi:10.1371/journal.pone.0122601.g002
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hypomethylated genes in CAP include ARHGDIB, HOXD4, S100A10, GLRX, TEX101,
SLC17A4, ST6GALNAC1, PAX9,MGC35206,HOXA7, SH2D2A, and ALX4; the hypermethy-
lated genes include NGEF, SLC22A14, C3orf35, ZNFN1A1, CCL28,and FABP1.
Differentially methylated CpG-sites for GSV and IMA tissues
A statistically significant difference in DNA methylation levels between IMA and GSV tissues
was identified for 335 CpG-sites (Fig 6; S3 Table). Among all differentially methylated CpG-
sites, 200 (59.7%) were hypermethylated in GSV compared to IMA. Gene ontology analysis for
genes harboring these CpG-sites revealed the enrichment for biological processes associated
with the development (S4 Table).
Using heatmap cluster analysis, 16 hypermethylated (HOXA5,HOXA2, PGBD3, VNN2,
THSD4, ELA2, CEP170, SCGB3A2, TOM1L1, SULF1, ALDH1A3, GP9, AVIL, SOST, TM4SF1,
and RBP1) and 8 hypomethylated (C1orf188, TMCO5,WT1,HSPB3, EMP1, C18orf16, GLRX,
and KRT23) genes were identified as significantly highly differentially methylated genes in the
GSV (Figs 6 and 7).
Pyrosequencing analysis at the promoter of HOXD4 gene in vascular
tissues
The maximal beta-value difference was detected between the CAP and IMA tissues for the CpG-
site cg01152019 in promoter of theHOXD4 gene. Represented on the array with reliable detec-
tion signals, a total of five CpG-sites were located about 1 kb upstream of theHOXD4 gene.
To verify the methylation level of theHOXD4 gene promoter, DNA from match-paired vas-
cular tissues of 15 additional patients, along with the samples used for the methylation profiling
in the array, was subjected to bisulfite treatment followed by pyrosequencing.
Fig 3. Multi-dimensional scaling for genome-wide methylation of right coronary artery in the area of advanced atherosclerotic plaques (CAP),
internal mammary arteries (IMA), and great saphenous veins (GSV). Arabic numbers are sample IDs.
doi:10.1371/journal.pone.0122601.g003
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The methylation values for 18 tissue samples obtained using Infinium array and pyrose-
quencing were found to be significantly correlated (for the CpG-site cg01152019 Pearson’s
R = 0.88, p<0.05).
Methylation levels in CAP tissues were significantly different from the average methylation
of other tissues (Table 3). Four CpG-sites in theHOXD4 promoter region were also confirmed
as hypomethylated in the independent dataset of CAP in comparison with IMA and GSV.
Table 2. Comparison of β-values (average ± s.d.) in paired vascular tissues from six patients with atherosclerosis.
CG-sites CG-sites
count (%)
CAP,
n = 6
IMA,
n = 6
Methylation differences CAP vs.
IMA (p-value)
GSV,
n = 6
Methylation differences CAP vs.
GSV (p-value)
All 27378 (100) 0.252
±0.03
0.247
±0.02
0.005 (<0.001) 0.250
±0.02
0.002 (<0.001)
Inside GpG-
islands
19993 (73) 0.129
±0.02
0.124
±0.01
0.005 (<0.001) 0.126
±0.01
0.003 (<0.001)
Outside CpG-
islands
7385 (27) 0.584
±0.05
0.583
±0.03
0.001 (>0.05) 0.584
±0.03
0 (>0.05)
CAP indicates right coronary arteries in the area of advanced atherosclerotic plaques; IMA, internal mammary arteries; GSV, great saphenous veins.
doi:10.1371/journal.pone.0122601.t002
Fig 4. Volcano plot of - log10 (P-value) against delta beta value, representing the methylation difference between right coronary arteries in the area
of advanced atherosclerotic plaques (CAP) and internal mammary arteries (IMA). A total of 194 CpG-sites hypermethylated in CAP with a delta
beta 0.2 and FDR-adjusted p<0.05 are shown in red. A total of 164 CpG-sites hypomethylated in CAP with a delta beta -0.2 and FDR-adjusted p<0.05
are shown in blue. CpG-sites that exhibited a methylation level difference less 20% are shown in grey. Light red and light blue colors indicate highly
differentially methylated CpG-sites (delta beta 0.40 or delta beta -0.40 with FDR-adjusted p<0.05). Dashed lines indicate cut-offs for significance.
doi:10.1371/journal.pone.0122601.g004
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Discussion
Aberrant DNAmethylation has been recognized as an important factor underlying the devel-
opment and progression of in various common diseases. A majority of studies conducted so far
have focused on cancer and only a few have investigated the role of epigenetic mechanisms,
such as DNAmethylation, in the development of cardiovascular disease [3]. To the best of our
knowledge, comparative DNAmethylation profiles of affected and healthy vascular tissues had
not been previously investigated in detail.
We analyzed quantitative single-base resolution DNA methylation patterns on a genome-
wide level in vascular tissues obtained from patients with atherosclerosis. We showed that
DNAmethylation age of vascular tissues was moderately related to chronological age. The
great saphenous veins had increased DNAmethylation age in comparison to the internal mam-
mary arteries. It has been established elsewhere, that GSV is a more differentiated tissue with
lower rates of cell proliferation and apoptosis as compared to IMA [18]. It is possible that high
DNAmethylation age of GSV may contribute to abnormal adaptation after coronary artery by-
pass grafting surgery.
We observed a high heterogeneity of DNAmethylation profiles of the CAP tissues. A plaque
constitutes many cell types and other components and, therefore, our finding was not surpris-
ing. The average methylation level for all the CpG-sites as well as inside the CpG-islands was
significantly higher in the CAP tissues, mainly due to lower frequency of the hypomethylated
CpG-sites, as compared with the IMA. Our results contradict to those published by Castillo-
Diaz et al. [10], who reported an extensive demethylation of normally hypermethylated CpG-
islands in human atherosclerotic arteries. This may partially be due to the different microarray
platforms used in the 2 studies. Castillo-Diaz et al. [10] used the single spotted array containing
14923 CpG-island clones of the UHN collections (Microarray Centre, Toronto, Canada), while
our data were generated using Infinium Human Methylation27 BeadChip.
Fig 5. Heatmap analysis of 22 highly differentially methylated CpG-sites (delta beta 0.40 or delta beta -0.40 with FDR-adjusted p<0.05)
between right coronary arteries in the area of advanced atherosclerotic plaques (CAP) and internal mammary arteries (IMA).Regions shaded blue
in the heat map represent hypomethylated regions, regions shaded red represent hypermethylated regions. The top black rectangles shows columns
representing CpG-sites located inside CpG-island. Gene symbols and CpG-site IDs are shown on the bottom. Sample IDs are on the right.
doi:10.1371/journal.pone.0122601.g005
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There is a body of evidences of a fundamental role of inflammation in the development and
progression of atherosclerotic plaque [19]. To date, several microarray studies have reported
on profiles of gene expression in human arteries, including advanced lesions and plaque-free
areas [20]. The analysis of biological pathways in expression studies indicated overrepresenta-
tion of up-regulated genes involved in control of inflammation. Our data confirmed that genes
hypomethylated in atherosclerotic-prone CAP tissues compared to atherosclerotic-resistant
IMA tissues are involved in inflammation and immune response.
Intriguingly, a high percentage of differentially methylated genes between vascular tissues
related to regulation of developmental process were revealed. One possible interpretation of
our findings is that these genes are involved in vascular tissue remodeling. Reactivation of the
developmental pathways is also needed during organ injury repair. Possibly, these genes are
upstream effectors that modulate other pathways that are involved in atherosclerosis. It has
been identified that the most highly variably DNA-methylated regions in several tissues were
significantly enriched by the development-related genes [21]. According to the authors, sto-
chastic epigenetic variation can be responsible for the development, evolutionary adaptation
and disease susceptibility. Heterogeneity in the origins of vascular tissues could also contribute
to the differences seen in developmental genes.
We also identified site-specific DNA methylation changes in comparison between the CAP
and IMA as well as GSV and IMA tissues. In our study the majority of differentially methylated
Fig 6. Volcano plot of - log10 (P-value) against delta beta value, representing the methylation difference between great saphenous veins (GSV) and
internal mammary arteries (IMA). A total of 200 CpG-sites hypermethylated in GSV with a delta beta 0.2 and FDR-adjusted p<0.05 are shown in red. A
total of 135 CpG-sites hypomethylated in GSV with a delta beta -0.2 and FDR-adjusted p<0.05 are shown in blue. CpG-sites that exhibited a methylation
level difference less 20% are shown in grey. Light red and light blue colors indicate highly differentially methylated CpG-sites (delta beta 0.40 or delta beta
 -0.40 with FDR-adjusted p<0.05). Dashed lines indicate cut-offs for significance.
doi:10.1371/journal.pone.0122601.g006
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CpG-sites were located in developmental genes, including HOX cluster (HOXA2,HOXA5,
HOXA7, HOXD4). Differential methylation region comparisons between athero-susceptible
and protected sites in swine arterial endothelial methylome also revealed a sharp distinction in
theHOX locus [22]. Aberrant homeobox CpG-island methylation is a frequent event in cancer
[23], thus suggesting overlapping epigenetic dysregulation in cancer and atherosclerosis.
The HOXD4 gene was found to be associated with differentially methylated CpG-island
both in the study of Castillo-Diaz et al. [10] and in our study, However, Castillo-Diaz et al. [10]
found that analyzed CpG-island was unmethylated in control, but hypermethylated in athero-
sclerotic artery. Conversely, we observed and confirmed by pyrosequencing a consistent hypo-
methylation of four CpG-sites located in theHOXD4 promoter region in CAP tissues as
Fig 7. Heatmap analysis of 27 highly differentially methylated CpG-sites (delta beta 0.40 or delta beta -0.40 with FDR-adjusted p<0.05)
between great saphenous veins (GSV) and internal mammary arteries (IMA). Regions shaded blue in the heat map represent hypomethylated regions,
regions shaded red represent hypermethylated regions. The top black rectangles shows columns representing CpG-sites located inside CpG-island. Gene
symbols and CpG-site IDs are shown on the bottom. Sample IDs are on the right.
doi:10.1371/journal.pone.0122601.g007
Table 3. Methylation level (mean ±SD) at the promoter of HOXD4 gene in paired vascular tissues from twenty one patients with atherosclerosis.
CG-site
(Illumina IDs)
CAP,
n = 21
IMA,
n = 21
Methylation differences CAP vs. IMA
(p-value)
GSV,
n = 21
Methylation differences CAP vs. GSV
(p-value)
CG1 (cg01152019) 0.129±0.04 0.610
±0.08
-0.481 (<0.001) 0.620±0.04 -0.491 (<0.001)
CG2 (cg14399060) 0.130±0.02 0.485
±0.07
-0.355 (<0.001) 0.408±0.06 -0.278 (<0.001)
CG3 0.258±0.06 0.686
±0.09
-0.428 (<0.001) 0.726±0.05 -0.468 (<0.001)
CG4 0.226±0.05 0.620
±0.13
-0.394 (<0.001) 0.526±0.06 -0.3 (<0.001)
All CG 0.186±0.04 0.600
±0.07
-0.414 (<0.001) 0.571±0.04 -0.385 (<0.001)
CAP indicates right coronary arteries in the area of advanced atherosclerotic plaques; IMA, internal mammary arteries; GSV, great saphenous veins.
doi:10.1371/journal.pone.0122601.t003
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compared to IMA and GSV. This result may be partly attributable to differences in the micro-
array platforms and the study subjects.
Although the functional significance of HOXD4 in atherosclerosis remains unclear, a previ-
ous study identified differential expression of this gene in the samples of human aorta with
varying degrees of atherosclerosis [24]. On the other hand, the region studied for the DNA
methylation encompasses four CpG-dinucleotides located withinMIR10B gene sequence.
MiR-10b is a microRNA associated with metastasis and/or invasiveness of various cancer types
[25]. It was shown that overexpression of miR-10b induces human microvascular endothelial
cell migration and angiogenesis via down-regulation of homeobox D10 (HOXD10) [26]. This
microRNA was also upregulated in advanced carotid plaques as compared with internal mam-
mary artery [27]. Further studies will be required to elucidate the functional significance of
methylation changes withinMIR10B gene sequence in atherosclerosis.
Hoxa2 andHoxa5 have been cloned from an adult rat vascular smooth muscle cDNA li-
brary, although the functions of these proteins were not determined in this study [28]. Hoxa5
is normally expressed in quiescent vessels, blocked angiogenesis and increased vascular stability
[29]. Recently, it was shown thatHoxA5 is regulated by flow in a DNAmethylation-dependent
manner and that Hoxa5 regulates endothelial inflammation [30]. Induction of disturbed blood
flow by partial carotid ligation surgery in a murine model resulted in hypermethylation within
the promoter ofHoxA5 and downregulation of gene expression in arterial endothelium [30].
Our study shows thatHOXA5 is hypermethylated in great saphenous veins as compared with
the internal mammary arteries that may contribute to aberrant remodeling of veins after coro-
nary artery bypass grafting surgery.
Some of the highly differentially methylated genes are also very interesting. First, in our study
S100A10 gene was hypomethylated in right coronary artery in the area of advanced atheroscle-
rotic plaques compared to atherosclerotic-resistant internal mammary arteries. S100A10 is high-
ly expressed in endothelial cells, macrophages and foam cells of complicated carotid plaque
segments [31]. This Ca2+-binding protein involved in the plasmin/plasminogen system regulat-
ing proteolytic activity and degradation of extracellular matrix, angiogenesis and macrophage in-
vasion. Second, we observed changes in the methylation level of GLRX gene in both comparisons
CAP vs. IMA and GSV vs. IMA. Expression ofGLRX gene is enhanced in endothelial cells,
smooth muscle cells and macrophages of human nonatherosclerotic and atherosclerotic coro-
nary arteries [32]. Glutaredoxin-1 is a cytosolic enzyme that regulates diverse cellular functions.
As speculated by Okuda et al. [32] glutaredoxin might be involved in the pathogenesis of athero-
sclerotic coronary heart disease via its antioxidant effect and/or its role as a signaling molecule.
Previous studies of vascular tissue samples revealed alterations in methylation of ALOX15,
ESR1, ESR2,MCT3 and TFPI2 genes in patients with atherosclerosis [5–9]. These genes were
covered by Infinium Human Methylation27 BeadChip, but they were not significantly differen-
tially methylated in our study.
We have not tested functional implications of changes in DNAmethylation, although this is
a subject of pivotal importance for the future studies. It should be noted, however, that Arch-
acki et al. [33] identified 29 genes differentially expressed between left anterior descending cor-
onary arteries and internal mammary arteries. Two genes (F13A1 and CD163) were found in
common with our list of differentially methylation genes.
A limitation of our study is an inability to attribute the methylation patterns to specific cell
types. The methylation patterns identified, consequently, may represent the gene set of methyla-
tion effect contributed from the different cells. Therefore differences in DNAmethylation can
result from changes in the proportions of cell types in atherosclerosis-affected and healthy vas-
cular tissue samples. To assess cell type-specific DNAmethylation of complex tissues, laser cap-
ture microdissection must be used. DNA yields from such samples, however, are too small to
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use with the current methods of microarray-based genome-wide DNAmethylation analysis. In
our approach, since the tissues were taken directly from patients with advance disease, the data
can be biased due to possible effects of unrecognized factors and drugs used for the treatment of
the patients. Unbiased results for vascular tissues can be achieved by sampling prior to the devel-
opment of the disease, but this is not feasible in humans. The major strength of our study is the
use of quantitative methods for the analysis of DNAmethylation at single-base resolution. We
also studied matched vascular tissues in order to avoid the effect of interindividual variation of
DNAmethylation patterns. Chen et al. [34] described a subset of CpG-sites that overlap known
SNPs. He proposed that studies that are focused on intraindividual differences rather than inter-
individual are not expected to be confounded by such underlying SNPs. We also check our two
lists of differentially methylated CpG-sites (S1 Table and S3 Table) using the list of polymorphic
CpG-sites [34]. There were one CpG-site that overlapped SNPs in the S1 Table (cg10222534)
and two CpG-sites in the S3 Table (cg19297688; cg22518733). These CpG-sites were not among
the top of our lists.
Conclusions
We performed a genome-wide DNAmethylation profiling study on the right coronary arteries
compared with internal mammary arteries and great saphenous veins from the same patients
with coronary heart disease. Modest, but consistent and significant, DNA methylation changes
in vascular tissues indicate the importance of epigenetic mechanisms in atherosclerosis. We re-
vealed that a high percentage of differentially methylated genes between vascular tissues related
to the regulation of the developmental process. This study identified hypomethylation of four
CpG-sites located within theMIR10B gene sequence and about 1 kb upstream of theHOXD4
gene in right coronary artery in the area of advanced atherosclerotic plaques in comparison
with the other vascular tissues. Further studies need to be carried out to investigate the genes
and biological pathways that are involved in the development of atherosclerosis and may serve
as targets for prevention and treating vascular diseases.
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